TABLE 1.

Baseline Characteristics of Patients With ALD Compared to Patients With Other Liver Disease Etiologies

Variable n (%) or Median (IQR)	ALD (42 Patients)	Others (40 Patients)	P Value*
Male sex	27/42 (64%)	14/40 (35%)	0.01
Female sex	15/42 (36%)	26/40 (65%)	0.01
Age (years)	57.5 (51‐62)	61 (56.75‐66.25)	0.07
Hispanic ethnicity	13/42 (31%)	9/40 (22%)	0.46
Non‐Hispanic ethnicity	29/42 (69%)	31/40 (77%)	0.46
White race	20/42 (48%)	18/40 (45%)	0.83
Asian race	0/42 (0%)	5/40 (12%)	0.05
Hispanic race	13/42 (31%)	9/40 (22%)	0.46
African American race	2/42 (5%)	3/40 (7%)	0.67
Public insurance	11/42 (26%)	16/40 (40%)	0.24
Medicare + commercial insurance	31/42 (74%)	24/40 (60%)	0.24
Received LT	15/42 (36%)	6/40 (15%)	0.04
Listed for LT	16/42 (38%)	11/40 (27%)	0.35
Declined for LT	19/42 (45%)	16/40 (40%)	0.66
ALP (U/L)	136.5 (89.25‐193)	145 (104.5‐203.25)	0.41
Albumin (g/dL)	2.65 (1.93‐3.6)	2.7 (2.05‐3.1)	0.65
ALT (U/L)	34.5 (24.25‐54)	52 (26.75‐168)	0.02
AST (U/L)	67.5 (45‐100.75)	101.5 (49.5‐305)	0.05
Creatinine (mg/dL)	1.71 (0.84‐2.34)	1.195 (0.75‐2.25)	0.46
INR	2.45 (1.8‐3.05)	1.95 (1.675‐2.6)	0.18
Sodium (mmol/L)	132 (126‐134.75)	135 (131.75‐140)	0.005
Total bilirubin (mg/dL)	9.85 (5.275‐15.775)	7.15 (3.3‐18.95)	0.51
MELD‐Na score	33 (28.25‐36)	28 (25.25‐33)	0.06
CLIF‐C score	55 (49‐60.75)	54.5 (51‐58)	0.74
SIPAT score	34 (25‐44)	23 (18‐30)	0.0005
ACLF grade 3	11/42 (26%)	7/40 (17%)	0.43
Referred from floor	39/42 (93%)	35/40 (87%)	0.48
Referred from ICU	3/42 (7%)	5/40 (13%)	0.48
Vasopressor support	2/42 (4.8%)	4/40 (10%)	0.42
Respiratory failure	1/42 (2.4%)	6/40 (15%)	0.05
HRS	12/42 (28.6%)	3/40 (7.5%)	0.02
HE	16/42 (38%)	14/40 (35%)	0.82

^* P < 0.05 is considered significant.

Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HE, hepatic encephalopathy; INR, international normalized ratio.